Market Overview

Pete Najarian Sees Unusual Options Activity In Gilead And KKR & Co.

Related GILD
Najarian Brothers See Unusual Options Activity In Procter & Gamble And Gilead
With $36.7B In Cash, Bank of America Expects Gilead To Shop For Complements To Drug Pipeline
Biotechs: Still Well Placed For More Gains (Seeking Alpha)
Related KKR
Benzinga's Top Upgrades, Downgrades For October 16, 2017
Wall Street's M&A Chatter From October 10: SeaWorld, Johnson Controls, Express Scripts-EviCore
KKR Is A Compelling Value (Seeking Alpha)

On CNBC's "Fast Money Halftime Report", Pete Najarian spoke about unusually high options activity in Gilead Sciences, Inc. (NASDAQ: GILD) and KKR & Co. L.P. (NYSE: KKR).

He noticed a purchase of 10,000 contracts of the May 90 calls in Gilead in the first half of the trading session. The trader paid 80 cents for them, which sets the break even for the trade at $90.80 at the May expiration. Najarian bought the stock and he is planning to sell upside calls against his long position as the stock moves higher.

Traders also bought 5,000 contracts of the March 24 calls in KKR & Co. L.P.. Najarian sees the purchase as aggressive and he decided to follow the trade.

Posted-In: Fast Money Halftime Report Pete NajarianCNBC Fast Money Options Markets Media


Related Articles (GILD + KKR)

View Comments and Join the Discussion!